Status:

ENROLLING_BY_INVITATION

Endoscopic Ultrasound Radiofrequency Ablation, Database Repository

Lead Sponsor:

Indiana University

Conditions:

Pancreatic Neoplasm

Eligibility:

All Genders

14+ years

Brief Summary

The purpose of having this database is to collect data related to endoscopic ultrasound RFA procedures performed by Indiana University EUS physicians for the treatment of tumors or adenopathy. This da...

Detailed Description

Radiofrequency ablation (RFA) is a well-established therapeutic option for ablation of dysplastic and neoplastic tissue by the use of local thermal coagulative necrosis. Options for administration inc...

Eligibility Criteria

Inclusion

  • Subjects 14 years of age and older Referral for the treatment of a benign or malignant tumor or adenopathy

Exclusion

  • Subjects less than 14 years of age Unable to comprehend the study consent due to language or disability

Key Trial Info

Start Date :

July 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2030

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04693754

Start Date

July 1 2020

End Date

December 31 2030

Last Update

February 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Indiana University Health University Hospital

Indianapolis, Indiana, United States, 46202-5121